A Comparative Clinical Study to Evaluate the Effect of Trivrutta Churna Nitya Virechana with Anupana as Sharkara and Go-Ghrita in Yakruta Vikara (Liver Disorders) with special reference to Abnormal Liver Function Tests (LFTs).

A Comparative Clinical Study on the Effect of Anupana Bheda Trivrutta Churna Nitya Virechana in Yakruta Vikara (Liver Disorders) with Abnormal Liver Function Tests.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/09/021072

Enrollment

Registered

2019-09-05

Start date

Unknown

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K70-K77- Diseases of liver Health Condition 2: K77- Liver disorders in diseases classified elsewhere

Interventions

Intervention1: Trivrutta Churna (Operculina turpethum) with Sharkara: Dose- Trivrutta Churna-7 gm and Sharkara 14 gm once in the morning, Duration â?? for 21 days. Mode of Administration- Oral. Contr

Eligibility

Inclusion criteria

Inclusion criteria: Ages of above 18 years and below 65 years Diagnosed Liver disorder with abnormal LFT

Exclusion criteria

Exclusion criteria: Known case of hepatitis-B or hepatitis-C Obstructive Liver Disease. Advanced liver disease (e.g. ascites, bleeding oesophageal varies and hepatic Encephalopathy, hepatic cancer, cirrhosis of liver). Subjects with serious illness,e.g.,uncontrolled diabetes, HIV, serious cardiovascular Disease.

Design outcomes

Primary

Measure	Time frame
To Evaluate the effect of Trivrutta Churna Nitya Virechana in Yakrut Vikara (Liver Diseases) with abnormal liver function test.Timepoint: 21 Days	—

Secondary

Measure	Time frame
To access the efficacy of Sagoghruta Nitya Virechana in the liver disorder.Timepoint: 21 days;To access the efficacy of Sasharkara Nitya Virechana in the liver disorder.Timepoint: 21 Days;To compare the efficacy of Nitya Virechana with Sharkara and Goghruta.Timepoint: 21 Days;To find out the relative early clinical and biological improvement between treatment groupsTimepoint: 21 Days;To measure the incidence of adverse events, adverse drug reactions, safety lab parameters (hematology, biochemistry) and vital during the study.Timepoint: 21 Days	—

Measure

Time frame

To access the efficacy of Sagoghruta Nitya Virechana in the liver disorder.Timepoint: 21 days;To access the efficacy of Sasharkara Nitya Virechana in the liver disorder.Timepoint: 21 Days;To compare the efficacy of Nitya Virechana with Sharkara and Goghruta.Timepoint: 21 Days;To find out the relative early clinical and biological improvement between treatment groupsTimepoint: 21 Days;To measure the incidence of adverse events, adverse drug reactions, safety lab parameters (hematology, biochemistry) and vital during the study.Timepoint: 21 Days

—

Countries

India

Contacts

Public ContactDr PATIL JAGDISH PRAKASHRAO

Mahatma Gandhi Ayurvedic Hospital and research center,, Salod (H), Wardha, Maharashtra.

drshwetaparve@gmail.com9403142270

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026